Increase in Infertility Rate among Adults Expected to Drive Global Fertility Drugs Market: Ken Research REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Fertility Drugs are drugs which are considered to be the primary treatment for treating the infertility in men and women. These drugs enhance the reproductive ability by improving the quality of egg or sperms by enhancing the levels of certain hormones in human body. Fertility drugs regulate the ovulation. These drugs generally work like the natural hormones luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to trigger ovulation. They are also used in women who ovulate for trying to stimulate a better egg or extra egg/eggs. These drugs may include Gonadotropins, Clomiphene citrate, Metformin etc. Apart from this, fertility drugs carry some risks such as Pregnancy with multiples, ovarian hyperstimulation syndrome (OHSS), and Long-term risks of ovarian tumors. According to study, “Fertility Drugs Market Global Report 2020-30” the key companies operating in the global fertility drugs market are Berlex Laboratories, Inc., Merck & Co. Pharmaceutical Company, Eli Lilly, Noven Pharmaceuticalorganon, Inc., Baxter Healthcare Corporation, Personal Products Company, Ferring Pharmaceauticals, Inc., Pfizer, Inc., Janssen Pharmaceuticals Inc., Ther-Rx Corporation, Leadiant Biosciences Inc., Procter & Gamble Pharmaceuticals, Solvay Pharmaceuticals, Inc., Emd Serono, Inc., Bayer Healthcare Pharmaceuticals, Actavis Generics, Roche Pharmaceutical, Takeda Pharmaceautical Co. Ltd. and Emd Serono Inc. The key companies are focusing on the product innovations, expansions, Mergers & Acquisition (M&A), finding new market in their core competency in order to increase individual market share. Based on gender type, fertility drugs market is segmented as male fertility treatment and female fertility treatment. Based on treatment type, market is segmented as Intra Cytoplasmic Sperm Injection (ICSI), In Vitro Fertilization (IVF), Hormonal, Alternative & Complementry Treatment and Intra Uterine Insemination (IUI). Based on infertility type, market is segmented as unexplained infertility, endometriosis, blocked or damaged tubes, polycystic ovarian syndrome, and others. Based on route of administration, market is segmented as intravenous, oral, intramuscular and subcutaneous. Based on type of drug, market is segmented as over-the-counter drugs and prescription fertility drugs. In addition, based on distribution channel, market is segmented as retail pharmacies, hospital pharmacies and online pharmacies. The fertility drugs market is driven by rise in prevalence of polycystic ovarian syndrome among younger women, followed by increase in average age of conceiving in women, change in lifestyle & cultural shift, increase in infertility rate among adults, surge in investment by pharma companies in fertility treatment centers, increase in sexually transmitted diseases among men & women and increase in government policies & schemes for infertility treatment. However, side-effects associated with fertility drugs such as birth defect, high cost of fertility drugs, black market of fertility drugs and high failure rate of treatment may impact the market. Moreover, growth in technological advancement, increase in awareness among people and growth in medical tourism are key opportunities for market. Based on geography, the North-American region holds major share in global fertility drugs market owing to rise in prevalence of sedentary lifestyles & obesity in the Americas, particularly in the U.S. The Asian-Pacific and European regions are estimated to witness higher growth rate due to increase in awareness about women’s health & fertility treatments over the forecast period. The global fertility drugs market was valued at US $4.26 billion in 2019 and it is likely to grow at a CAGR of 5.80% and reach US $5.33 billion by 2023. For More Information, Click on the Link Below:- Global Fertility Drugs Market Related Report:- Global Fertility Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Asia-Pacific Fertility Drugs Market, Bayer Fertility Drugs Market Revenue, Berlex Laboratories Inc Fertility Drugs Market Share, COVID-19 Impact on Global Fertility Drugs Industry, COVID-19 Impact on Global Fertility Drugs Market, Europe Fertility Drugs Market, Ferring Pharmaceuticals Fertility Drugs Market Share, Fertility Drug Market Development, Fertility Drug market Future, Fertility Drug Market Growth, Fertility Drug market Top Manufacturers, Fertility Drug Sales market, Fertility Drugs Market, Fertility Drugs Market Analysis, Fertility Drugs Market Application, Fertility Drugs Market Competitive Landscape, Fertility Drugs Market Forecast, Fertility Drugs Market Overview, Fertility Drugs Market Research, Fertility Drugs Market Share, Fertility Drugs Market Trends, Fertility Test Market, Germany Fertility Drugs Market, Global Fertility Drugs Industry, Global Fertility Drugs Industry Research Report, Global Fertility Drugs Market, Global Fertility Drugs Market Research Report, Infertility Treatment Market, Japan Fertility Drugs Market, Market Research Report of Global Fertility Drugs, Prescription Fertility Drugs Market, UK Fertility Drugs Market